Dublin, May 01, 2026 (GLOBE NEWSWIRE) — The “Substance Abuse Treatment Market: Analysis by Treatment Type; End-use; Region – Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035” has been added to ResearchAndMarkets.com’s offering.
The Substance Abuse Treatment Market is set for remarkable growth, with an estimated value rising from USD 15.72 billion in 2025 to USD 39.49 billion by 2035, reflecting a robust CAGR of 9.65% between 2026 and 2035. This expansion underscores the urgent global need to address substance use disorders.
As addiction rates increase across diverse groups, the demand for both inpatient and outpatient treatment services has surged. Substance use disorders are now recognized as complex health issues requiring structured, multidimensional, and long-term care approaches. The adoption of technology, including telehealth platforms and data-driven care models, is pivotal in enhancing treatment accessibility and effectiveness. These tools facilitate care for those facing stigma, geographic challenges, or limited access to specialized providers, integrating clinical care, behavioral support, medication-assisted treatment, and digital engagement for better recovery outcomes.
Noteworthy Market Developments
The market is shifting from a fragmented provider ecosystem to a consolidated landscape dominated by key players. This structural change has led to an oligopolistic environment, where large, omni-channel healthcare organizations and well-capitalized digital firms dictate pricing and service standards. Notable market leaders include Acadia Healthcare and Universal Health Services, expanding through joint ventures and extensive facility networks. Additionally, the Hazelden Betty Ford Foundation exemplifies dominance in high-quality care, while innovation-driven groups like Groups Recover Together are transforming outpatient medication-assisted treatment.
Core Growth Drivers
The rise in substance abuse treatment demand arises from a growing consumer base and persistent gaps in care access. An estimated 39.5 million individuals globally suffer from severe drug use disorders. Despite increased awareness, challenges such as limited treatment capacity and funding hinder care access, emphasizing the need for expanded networks and integrated mental health support.
Emerging Opportunity Trends
Gen Z’s entry into the treatment market introduces complex clinical profiles, emphasizing care models that are trauma-informed and culturally sensitive. This generation values technology-enabled environments that support diverse identities and inclusive care, integrating addiction treatment with mental health services, and personalized recovery pathways.
Barriers to Optimization
The industry faces a significant workforce shortage, with a 25% deficit in essential clinical roles. This shortage has amplified wage inflation and increased care delivery costs, limiting treatment availability and increasing wait times. Addressing these staffing constraints is crucial for expanding access and scaling infrastructure.
Detailed Market Segmentation
- Treatment Type: Tobacco/Nicotine and Vaping; Alcohol; Marijuana; Synthetic Cannabinoids; Prescription Medications; Others.
- End-use: Hospitals, Clinics, Rehabilitation Centers, Others.
- Geographical Breakdown:
- North America: U.S., Canada, Mexico
- Europe: Western, Eastern Europe
- Asia-Pacific: China, India, Japan, Australia & New Zealand, South Korea, ASEAN, Rest of Asia-Pacific
- MEA: Saudi Arabia, South Africa, UAE, Rest of MEA
- South America: Argentina, Brazil, Rest of South America
Asia-Pacific is emerging as a significant growth region, with a forecasted CAGR of 9.5%. Cultural stigma historically constrained this growth, but rising wealth and government initiatives are fueling demand for professional care. The proliferation of localized therapy apps and telehealth platforms aids accessibility, particularly for younger, tech-savvy users.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 260 |
| Forecast Period | 2025-2035 |
| Estimated Market Value (USD) in 2025 | $15.72 Billion |
| Forecasted Market Value (USD) by 2035 | $39.49 Billion |
| Compound Annual Growth Rate | 9.6% |
| Regions Covered | Global |
A selection of companies mentioned in this report includes, but is not limited to:
- Accord Healthcare
- Amphastar Pharmaceuticals
- Apotex
- BioCorRx
- Cipla
- Glenmark
- INSYS Therapeutics
- LFB Group
- Lupin
- Mylan Laboratories
- Opiant Technologies
- Sanofi Aventis
- Sanquin.
- Sterinova
- Sun Pharma
- Teva Pharmaceutical
For more information about this report visit https://www.researchandmarkets.com/r/ufru48
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Substance Abuse Treatment Market
